medsovetМедицинский СоветMeditsinskiy sovet = Medical Council2079-701X2658-5790REMEDIUM GROUP Ltd.10.21518/2079-701X-2014-17-53-59medsovet-775Research ArticleКАРДИОЛОГИЯCARDIOLOGYСовременные подходы к ведению больных с легочной гипертензиейCurrent approaches to management of patients with pulmonary hypertensionАвдеевС. Н.AvdeevS. N.noemail@neicon.ruНИИ пульмонологии ФМБА РоссииРоссияResearch Institute of Pulmonology, Federal Medical and Biological Agency of RussiaRussian Federation2014301220140175359Copyright © Авдеев С.Н., 20142014Авдеев С.Н.Avdeev S.N.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.med-sovet.pro/jour/article/view/775

Легочная гипертензия - группа заболеваний, характеризующихся прогрессивным повышением легочного сосудистого сопротивления, что ведет к правожелудочковой недостаточности и преждевременной смерти. По разным данным, распространенность легочной гипертензии может достигать 50 : 1 000 000 населения. Наиболее подвержены развитию идиопатической легочной гипертензии молодые женщины в возрасте от 20 до 40 лет. У мужчин это заболевание встречается реже. В последние годы изучению этого вопроса уделяется значительное внимание, и проблема своевременной и эффективной диагностики и лечения легочной гипертензии является весьма актуальной.

Pulmonary hypertension is a group of diseases characterized by progressive increase in pulmonary vascular resistance leading to right ventricular failure and premature mortality. According to various sources, the prevalence of pulmonary hypertension may reach up to 50 per 1,000,000 population. Young females aged 20 to 40 years are the most likely candidates for idiopathic pulmonary hypertension. In men, the disease is less common. The disease has received considerable attention recently: timely and effective diagnosis and treatment of pulmonary hypertension is a relevant issue.

легочная гипертензиялегочная артериальная гипертензиядиагностикалечениепростаноидилопростингаляционная формаpulmonary hypertensionpulmonary arterial hypertensiondiagnosistreatmentprostanoid iloprostinhalerReferencesHoeper MM, Bogaard HJ, Condliffe R et al. Definitions and Diagnosis of Pulmonary Hypertension. J Am Coll Cardiol, 2013, 62 (Suppl. 25): D42-50.Hoeper MM, Bogaard HJ, Condliffe R et al. Definitions and Diagnosis of Pulmonary Hypertension. J Am Coll Cardiol, 2013, 62 (Suppl. 25): D42-50.Galie N, Hoeper M, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Heart J, 2009, 30: 2493-2537.Galie N, Hoeper M, Humbert M et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS). Eur Heart J, 2009, 30: 2493-2537.Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J, 2009, 34: 1219-1263.Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J, 2009, 34: 1219-1263.Hatano S, Strasser T. Primary Pulmonary Hypertension: Report of a WHO Meeting. Geneva, WHO, 1975.Hatano S, Strasser T. Primary Pulmonary Hypertension: Report of a WHO Meeting. Geneva, WHO, 1975.D'Alonzo GE, Barst RJ, Ayres SM et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry Ann Intern Med, 1991, 115: 343-349.D'Alonzo GE, Barst RJ, Ayres SM et al. Survival in patients with primary pulmonary hypertension. Results from a national prospective registry Ann Intern Med, 1991, 115: 343-349.Macchia A, Marchioli R, Marfisi R, et al. A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology. Am Heart J, 2007, 153: 1037-1047.Macchia A, Marchioli R, Marfisi R, et al. A meta-analysis of trials of pulmonary hypertension: a clinical condition looking for drugs and research methodology. Am Heart J, 2007, 153: 1037-1047.Oudiz RJ. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med, 2007, 28: 233-241.Oudiz RJ. Pulmonary hypertension associated with left-sided heart disease. Clin Chest Med, 2007, 28: 233-241.Simonneau G, Galie N, Rubin L et al. Clinical classification of pulmonary arterial hypertension. J Am Coll Cardiol, 2004, 43: S5-12.Simonneau G, Galie N, Rubin L et al. Clinical classification of pulmonary arterial hypertension. J Am Coll Cardiol, 2004, 43: S5-12.Pietra GG, Edwards WD, Kay JM et al. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation, 1989, 80: 1198-206.Pietra GG, Edwards WD, Kay JM et al. Histopathology of primary pulmonary hypertension. A qualitative and quantitative study of pulmonary blood vessels from 58 patients in the National Heart, Lung, and Blood Institute, Primary Pulmonary Hypertension Registry. Circulation, 1989, 80: 1198-206.Pietra GG, Capron F, Stewart S et al. Pathologic assessment of vasculopathies in pulmonary hypertension. 2004, S25-32.Pietra GG, Capron F, Stewart S et al. Pathologic assessment of vasculopathies in pulmonary hypertension. 2004, S25-32.

The authors declare that there are no conflicts of interest present.